Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Artificial intelligence-based radiomic approaches have been shown to accurately evaluate...
Accurate subtyping of lung cancer is essential for improving patient prognosis and enabling personal...
BACKGROUND: Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are difficult to manage because ...
Chimeric antigen receptor (CAR) T-cell therapy has transformed the management of hematologic maligna...
Therapeutic resistance remains the principal barrier to durable clinical benefit in oncology, partic...
Time-of-flight (ToF) in PET improves image quality by enhancing the signal-to-noise ratio, and recen...
BACKGROUND: Sinonasal inverted papilloma(SNIP) is a benign tumor with a potential of malignant trans...
As artificial intelligence (AI) has been proposed to aid in the clinical management of leukemia, we ...
Cells must adopt flexible regulatory strategies to make decisions regarding their fate, including di...
Digital breast tomosynthesis (DBT) increases sensitivity and specificity compared to digital mammogr...
Breast cancer diagnosis from histopathological images remains a critical yet challenging task due to...
Cell-free DNA in blood originates from fragmented chromatin released by dying cells from both health...
Prostate cancer exhibits complex transcriptional heterogeneity that underlies disease progression an...
Immunotherapy with immune checkpoint blockade (ICB) in epithelial ovarian carcinoma (EOC) shows limi...
Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality worldwide, highlighti...
OBJECTIVE: Soft tissue sarcomas (STS) are a rare and heterogeneous group of tumors that pose a signi...
RNA therapeutics have progressed into a disruptive drug class quickly, replacing a variety of primar...
UNLABELLED: Anthracycline-induced cardiotoxicity remains a significant clinical challenge. We evalua...
BACKGROUND: Prostate cancer represents the second most common malignancy among men globally, necessi...
Neoadjuvant systemic therapy has emerged as a strategy to improve outcomes in high-risk localized ge...
BACKGROUND AND OBJECTIVE: Gastric cancer is a heterogeneous and complicated epithelial cancers. Chro...